Application | Comment | Organism |
---|---|---|
drug development | Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis | Mus musculus |
drug development | drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis. Inhibiting LTB4 biosynthesis and subsequently neutrophilic inflammation may provide a potential strategy for the treatment of acute lung injury (ALI) and idiopathic pulmonary fibrosis (IPF) | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
enzyme in complex with inhibitors SAHA or M344, X-ray diffraction structure determination and analysis | Homo sapiens |
enzyme in complex with inhibitors SAHA or M344, X-ray diffraction structure determination and analysis | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid | - |
Homo sapiens | |
(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid | - |
Mus musculus | |
3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]-propanoic acid | - |
Homo sapiens | |
3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]-propanoic acid | - |
Mus musculus | |
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide | enzyme binding structure, overview | Homo sapiens | |
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide | markedly diminishes early neutrophilic inflammation in mouse models of ALI and IPF under a clinical safety dose, enzyme binding structure, overview | Mus musculus | |
abexinostat | - |
Homo sapiens | |
abexinostat | - |
Mus musculus | |
belinostat | - |
Homo sapiens | |
belinostat | - |
Mus musculus | |
CUDC-101 | - |
Homo sapiens | |
CUDC-101 | - |
Mus musculus | |
entinostat | - |
Homo sapiens | |
entinostat | - |
Mus musculus | |
givinostat | - |
Homo sapiens | |
givinostat | - |
Mus musculus | |
JNJ-26481585 | - |
Homo sapiens | |
JNJ-26481585 | - |
Mus musculus | |
mocetinostat | - |
Homo sapiens | |
mocetinostat | - |
Mus musculus | |
additional information | drug repurposing of histone deacetylase (HDAC) inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis, overview. Analysis of potential inhibitors of LTA4H across a panel of 18 HDAC inhibitors, using enzymatic assay, thermofluor assay, and X-ray crystallographic investigation. Detailed mechanisms of down-regulation of proinflammatory cytokines by SAHA or M344 are determined in vivo. Cotreatment of N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide and (S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid synergistically represses the migration of neutrophil and LTB4-induced neutrophil migration is not affected by these treatments. Molecular modelling of HDAC inhibitors against LTA4H hydrolase and aminopeptidase | Homo sapiens | |
additional information | drug repurposing of histone deacetylase (HDAC) inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis, overview. Analysis of potential inhibitors of LTA4H across a panel of 18 HDAC inhibitors, using enzymatic assay, thermofluor assay, and X-ray crystallographic investigation. Detailed mechanisms of down-regulation of proinflammatory cytokines by SAHA or M344 are determined in vivo. Cotreatment of N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide and (S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid synergistically represses the migration of neutrophil and LTB4-induced neutrophil migration is not affected by these treatments. Molecular modeling of HDAC inhibitors against LTA4H hydrolase and aminopeptidase | Mus musculus | |
N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide | - |
Homo sapiens | |
N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide | - |
Mus musculus | |
panobinostat | - |
Homo sapiens | |
panobinostat | - |
Mus musculus | |
pracinostat | - |
Homo sapiens | |
pracinostat | - |
Mus musculus | |
resminostat | - |
Homo sapiens | |
resminostat | - |
Mus musculus | |
rocilinostat | - |
Homo sapiens | |
rocilinostat | - |
Mus musculus | |
scriptaid | - |
Homo sapiens | |
scriptaid | - |
Mus musculus | |
suberanilohydroxamic acid | enzyme binding structure, overview | Homo sapiens | |
suberanilohydroxamic acid | markedly diminishes early neutrophilic inflammation in mouse models of ALI and IPF under a clinical safety dose, enzyme binding structure, overview | Mus musculus | |
trichostatin A | - |
Homo sapiens | |
trichostatin A | - |
Mus musculus | |
tubacin | - |
Homo sapiens | |
tubacin | - |
Mus musculus | |
Valproate | - |
Homo sapiens | |
Valproate | - |
Mus musculus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | zinc metalloenzyme, enzyme LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Homo sapiens | |
Zn2+ | zinc metalloenzyme, enzyme LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
leukotriene A4 + H2O | Homo sapiens | - |
leukotriene B4 | - |
? | |
leukotriene A4 + H2O | Mus musculus | - |
leukotriene B4 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P09960 | - |
- |
Mus musculus | P24527 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
neutrophil | - |
Homo sapiens | - |
neutrophil | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
leukotriene A4 + H2O | - |
Homo sapiens | leukotriene B4 | - |
? | |
leukotriene A4 + H2O | - |
Mus musculus | leukotriene B4 | - |
? | |
additional information | the aminopeptidase binding site shares a similar structure to LTA4H at its ligand binding sites | Homo sapiens | ? | - |
? | |
additional information | the aminopeptidase binding site shares a similar structure to LTA4H at its ligand binding sites | Mus musculus | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Homo sapiens |
More | LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Mus musculus |
Synonyms | Comment | Organism |
---|---|---|
leukotriene A4 hydrolase | - |
Homo sapiens |
leukotriene A4 hydrolase | - |
Mus musculus |
LTA4H | - |
Homo sapiens |
LTA4H | - |
Mus musculus |
More | see also EC 3.4.11.6 | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00068 | - |
pH and temperature not specified in the publication | Homo sapiens | 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide | |
0.00068 | - |
pH and temperature not specified in the publication | Mus musculus | 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide | |
0.00765 | - |
pH and temperature not specified in the publication | Homo sapiens | suberanilohydroxamic acid | |
0.00765 | - |
pH and temperature not specified in the publication | Mus musculus | suberanilohydroxamic acid | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | trichostatin A | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | trichostatin A | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | Valproate | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | Valproate | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | tubacin | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | tubacin | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | JNJ-26481585 | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | JNJ-26481585 | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | belinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | belinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | entinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | entinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | scriptaid | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | scriptaid | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | panobinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | panobinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | mocetinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | mocetinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | resminostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | resminostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | abexinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | abexinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | CUDC-101 | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | CUDC-101 | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | givinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | givinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | N-(6-(2-aminophenylamino)-6-oxyhexyl)-4-methylbenzamide | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | pracinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | pracinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Homo sapiens | rocilinostat | |
0.01 | - |
above, pH and temperature not specified in the publication | Mus musculus | rocilinostat |
General Information | Comment | Organism |
---|---|---|
malfunction | LTB4 levels are persistently elevated in bronchoalveolar lavage fluid (BALF) of lipopolysaccharide (LPS)-induced ALI, and the leukotriene levels in pulmonary edema fluid are significantly higher in ALI patients compared to control patients with hydrostatic pulmonary edema. In addition, LTB4 level is increased in lung homogenates, and BALF of patients with IPF and the level of LTB4 correlate with the extent of fibrosis in histological sections | Homo sapiens |
additional information | LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Homo sapiens |
additional information | LTA4H folds into three domains and creates a deep cleft harboring the catalytic Zn2+ site, forming the active site with an L-shaped hydrophobic pocket deep into the protein | Mus musculus |
physiological function | leukotriene A4 hydrolase (LTA4H) is a bifunctional enzyme that exhibits LTA4H and aminopeptidase activities, it is a key enzyme in the biosynthesis of leukotriene B4 (LTB4). LTA4H is well-known to regulate chemotactic activity of human neutrophils. LTB4 is secreted by neutrophils at inflammation sites in response to formyl peptides, playing an important role in neutrophil activation and migration to formyl peptides | Homo sapiens |
physiological function | leukotriene A4 hydrolase (LTA4H) is a key enzyme in the biosynthesis of leukotriene B4 (LTB4) | Mus musculus |